Oncology Business Management | Specialty

The OncLive Oncology Business Management condition center page is a comprehensive resource for news and expert insights on business-focused updates and topics in oncology practices, including diversity efforts, telehealth, gaps in care, payment models, and more. This page features news articles, interviews in written and video format, and podcasts that focus on updates and best practices with oncology business management.


Emerging Biomarkers for Lung Cancer

July 19th 2016

PD-L1 Biomarker Testing

July 19th 2016

Immunotherapy for Brain Metastases

July 19th 2016

Managing Toxicity in Immunotherapy for Lung Cancer

July 19th 2016

The Role of Immunotherapy in Metastatic NSCLC

July 19th 2016

Up-front Treatment Options for Squamous NSCLC

July 19th 2016

Progression in Non-Driver Adenocarcinoma

July 19th 2016

Treatment Approaches in Non-Driver Adenocarcinoma

July 19th 2016

ALK-Positive NSCLC

July 19th 2016

EGFR TKI Sequencing

July 19th 2016

Osimertinib for the T790M Resistance Mutation

July 19th 2016

TKIs for EGFR Del19 and Beyond Progression

July 19th 2016

Refining Use of EGFR TKIs, Adding Bevacizumab

July 19th 2016

Molecular Testing in Squamous Cell Tumors

July 19th 2016

The Emergence of Liquid Biopsy in Lung Cancer

July 19th 2016

The Importance of Comprehensive Genomic Profiling

July 19th 2016

Lung Cancer Molecular Testing

July 19th 2016

Threefold Growth in Cancer Center Ads

July 19th 2016

Television garners the most advertising dollars from cancer centers, but print and Internet media have seen threefold increases in cancer ads,

CMS: Oncology Care Model Will Be Tough But Worth It

July 19th 2016

Ron Kline, MD, explains that there are bound to be technical difficulties with an ambitious program such as the Oncology Care Model.

FDA Grants Nivolumab Priority Review for Head and Neck Cancer

July 18th 2016

The FDA has granted a priority review designation to nivolumab as a treatment for patients with previously treated metastatic or recurrent squamous cell carcinoma of the head and neck.